Accelerating the development of new health technologies for urgent needs
RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - COMMERCIALIZATION CENTER
This study is all about finding faster ways to create new health technologies, like tests for diseases such as Alzheimer's and hepatitis B, to help improve patient care at home and in clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Venturewell NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-11220152 on NIH RePORTER |
What this research studies
This research focuses on speeding up the creation and implementation of innovative health technologies to meet pressing health challenges. The Commercialization Center will provide essential expertise and resources to support the development of up to ten health technology initiatives, including diagnostics for diseases like Alzheimer's and hepatitis B. By leveraging a collaborative approach across various biomedical fields, the center aims to enhance the availability of technologies that can be used in clinical settings or at home, ultimately improving patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals affected by Alzheimer's disease, hepatitis B, or other chronic and infectious diseases.
Not a fit: Patients with conditions not addressed by the targeted health technologies, or those who do not require new diagnostic or treatment options, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster access to advanced health technologies that improve diagnosis and treatment for various conditions.
How similar studies have performed: Previous initiatives in health technology commercialization have shown promise in accelerating the development of effective diagnostic and treatment solutions.
Where this research is happening
Hadley, United States
- Venturewell — Hadley, United States (Active)
Researchers
- Principal investigator: Marino, Mark — Venturewell
- Study coordinator: Marino, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.